GLP-1 Coverage & Costs in Nevada (2026)
$79/month (Embody, compounded semaglutide, monthly plan) is the lowest monthly-plan price we have recorded among the programs on this page. Embody lists 48 states and our records do not name them, so confirm Nevada at intake.
The lowest recorded compounded tirzepatide price is $129/month (Embody, monthly plan). Among programs recorded as available in all 50 states, the lowest is $139/month (AgelessRx, compounded semaglutide, monthly plan). 6 of the 49 programs listed have no recorded price. Recorded prices cover medication and known program fees, not a verified total.
Nevada Medicaid Coverage for GLP-1
Medicaid: not covered as of January 2026 (KFF)
KFF's map lists Nevada as not covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan.
- Source: KFF, Medicaid Coverage of and Spending on GLP-1s, Figure 1 (January 16, 2026). Read 2026-11-06.
Your Options in Nevada:
- Telehealth programs: recorded compounded prices from $79/month on a monthly plan, where the program serves Nevada
- Commercial or employer insurance: check your plan's drug list and prior authorization rules
- Medicare GLP-1 Bridge for eligible Part D enrollees (see below)
Nevada Medicaid GLP-1 Prescriptions in 2025
70,791
#30
$77.1 million
Ozempic
Nevada Medicaid paid for 70,791 GLP-1 prescriptions in 2025, 0.6% of the 11.26 million paid nationally and number 30 of 51 (50 states and DC). It reimbursed pharmacies $77.1 million before manufacturer rebates, about $1,090 per prescription, and the most-filled product was Ozempic. These counts include diabetes prescriptions, not only weight loss. Wegovy, Zepbound and Saxenda, the brands approved for chronic weight management, made up 1,240 of those prescriptions (1.8%). Wegovy and Zepbound also carry other approved uses, so this is an upper bound on weight-loss use, not a count of it.
From 2021 to 2025, Nevada Medicaid GLP-1 prescriptions went from 27,540 to 70,791, 2.6 times the 2021 count. From 2024 to 2025 the count rose by 16,026.
27,540
39,189
40,441
54,765
70,791
| Product | NV Medicaid prescriptions, 2025 | Share |
|---|---|---|
| Ozempic | 42,402 | 59.9% |
| Mounjaro | 19,176 | 27.1% |
| Trulicity | 4,482 | 6.3% |
| Liraglutide (generic) | 1,792 | 2.5% |
| Rybelsus | 1,671 | 2.4% |
| Wegovy | 876 | 1.2% |
| Zepbound | 364 | 0.5% |
| Bydureon | 28 | under 0.1% |
Source: CMS State Drug Utilization Data, 2025 (updated July 13, 2026), fee-for-service and managed care, all four quarters, compiled in our network's PriceTracker GLP-1 state table (read October 4, 2026); 2021 to 2024 summed by us from CMS's own yearly datasets with the same method, read November 9, 2026. CMS hides rows under 11 prescriptions, so small counts are slightly low. CMS publishes no per-enrollee rate here, so a total reflects the size of the program as much as use.
Nevada Employee Plan and Insurer GLP-1 Rules
Nevada Public Employees' Benefits Program (PEBP)
Covers with limitsNevada's PEBP provides weight-loss medications through its voluntary, opt-in Obesity Care Management Program, alongside medically supervised weight loss and nutritional counseling, per its plan year 2026 benefit guide.
The plan year 2026 benefit guide describes the Obesity Care Management Program and lists weight-loss medications among what it provides.
“Obesity Care Management Program – This is a voluntary “opt-in” program that provides, but is not limited to, medically supervised weight loss program, nutritional counseling, weight-loss medications.”
Source: Nevada Public Employees' Benefits Program. Read October 29, 2026.
We have no Nevadainsurer policy on record yet. Most commercial plans decide GLP-1 coverage plan by plan, so the employer's choice matters as much as the insurer.
Comparing self-pay programs in Nevada?
2-minute quiz: filter by budget and medication preference.
Telehealth Programs to Check for Nevada
We list 49 programs here. 21 are recorded as available in all 50 states. 7 more publish their own state list, summarized below for Nevada. The rest record a state count without naming the states, so confirm Nevada with the program at intake before you pay.
What Programs' Own Pages Say About Nevada
8 of the 8 programs whose own pages name the states they serve include Nevada: Willow, SnagRx, Strut Health, MangoRx, Wellorithm, MEDGm, TelosRx, Trimi. Pages read November 9, 2026. This is what each seller states about availability, not a licensing check.
| Program | Nevada |
|---|---|
| Willow | Serves NV |
| SnagRx | Serves NV |
| Strut Health | Ships to NV |
| MangoRx | Ships to NV |
| Wellorithm | Serves NV |
| MEDGm | Serves NV |
| TelosRx | Serves NV |
| Trimi | Serves NV |
Trimi's state table lists Nevada as served through the Arora Health network. Visit format there: Online intake reviewed by a licensed provider; no in-person visit required. The telehealth law it cites for Nevada is Nev. Rev. Stat. 629.515(4). That citation is Trimi's, not our legal reading. Trimi state table, read November 9, 2026.
Programs on Our List, in Published Order
Compounded GLP-1 care with one-month and prepaid plans
Personalized GLP-1 consultations with tailored prescriptions and ongoing physician support
Affordable compounded semaglutide from $119/mo with free shipping and health coaching
Personalized GLP-1 weight loss with licensed providers and nationwide coverage
45 more programs on our list: 19 recorded as available in all 50 states, 7 with a state list shown in the table above, and 19 with a state count but no published list we have read. Compare all of them side by side.
Estimated GLP-1 Costs in Nevada
Telehealth (Compounded)
$79 to $399/moRecorded monthly-plan prices for compounded semaglutide and tirzepatide. Availability varies by program, so confirm your state at intake.
Wegovy
Brand prices with and without insurance.
Zepbound
List, LillyDirect and savings card prices.
No insurance
Self-pay GLP-1 options without coverage.
The compounded range is our recorded monthly-plan prices, the same in every state. Brand and insurance costs depend on the plan, so we link the pages that carry their sources. Compounded medications are not FDA-approved.
Medicare Part D GLP-1 Claims in Nevada, 2024
Nevada prescribers wrote 154,929 Medicare Part D GLP-1 claims in 2024, number 35 of 51, with $212.2 million in gross drug cost before rebates. Ozempic led with 74,038 claims for 16,227 enrollees. Wegovy had 998 claims. Part D did not pay for weight loss alone in 2024, so these fills are for diabetes and other approved uses.
| Product | NV Part D claims | Enrollees |
|---|---|---|
| Ozempic | 74,038 | 16,227 |
| Mounjaro | 42,871 | 8,129 |
| Trulicity | 25,223 | 5,465 |
| Rybelsus | 9,137 | 2,717 |
| Victoza | 1,439 | Not given |
| Wegovy | 998 | 277 |
| Bydureon Bcise | 954 | 252 |
| Liraglutide | 233 | 107 |
| Byetta | 36 | 14 |
Source: CMS Medicare Part D Prescribers by Geography and Drug, 2024 (updated May 21, 2026), state rows, read November 9, 2026. The state is the prescriber's. Claims include refills, and enrollees are not added across products because one person can fill two.
Medicare GLP-1 Bridge Program in Nevada
The Bridge is national, so the rules are the same in Nevada as everywhere: eligible Part D enrollees pay $50/month for Foundayo, Wegovy or Zepbound KwikPen, subject to BMI rules and exclusions. Medicare fact sheet.
$50/mo
July 1, 2026
Dec 31, 2027
How Nevada Compares to Other West States
Medicaid coverage of GLP-1s for obesity is optional for states, so the answer differs by state. Here is how Nevada and its neighbors in the West are recorded:
| State | Medicaid and GLP-1s for obesity | Medicaid GLP-1 Rx, 2025 |
|---|---|---|
| Nevada (this page) | Not covered | 70,791 |
| California | Not covered | 3,089,327 |
Our recorded telehealth prices are not state-specific: $79 to $399/month on monthly plans. Medicaid and marketplace coverage is what varies.
KFF counted 13 state Medicaid programs covering GLP-1s for obesity under fee-for-service as of January 2026. Managed care plans may differ. Later counts may be lower: The RX Index, an independent tracker, listed 11 in a July 10, 2026 snapshot and says that is not a current national count. Sources read November 6, 2026. Policies change, so confirm with your state Medicaid agency or plan.
GLP-1 Guides for Nevada Cities
If Your Insurance Denies GLP-1 Coverage in Nevada
Commercial plans offer an internal appeal, then external review; Nevada Medicaid enrollees can ask for a fair hearing. The denial letter names the deadlines.
How to Check Your Specific Plan in Nevada
- Nevada Medicaid: Medicaid: not covered as of January 2026 (KFF). Ask your Medicaid plan for its drug list and prior authorization rules, or find the state agency on Medicaid.gov's state contacts.
- State employees: Nevada Public Employees' Benefits Program (PEBP), covers with limits per the documents cited above. Confirm with the plan before you fill a prescription.
- Any other plan: call the number on your card and ask whether Wegovy or Zepbound is covered for weight loss, which tier it sits on, and what prior authorization needs. Get the answer in writing.
Find the Right GLP-1 Provider in Nevada
Answer a few questions and we'll match you with the best GLP-1 program for your budget, insurance, and goals in Nevada.
Frequently Asked Questions — Nevada
Does Nevada Medicaid cover GLP-1 medications for weight loss?
How many GLP-1 prescriptions did Nevada Medicaid pay for in 2025?
How many Medicare Part D GLP-1 claims were there in Nevada in 2024?
Does the Nevada state employee health plan cover GLP-1s for weight loss?
What is the cheapest way to get GLP-1 medication in Nevada?
Which online GLP-1 programs serve Nevada?
Does Medicare cover GLP-1s in Nevada?
Ready to start?
Compare the recorded costs, sources and evidence gaps for 52 listed providers. Confirm current terms with the provider before enrolling.